Navigation Links
IDM Pharma Announces Updated Phase 3 Mifamurtide (L-MTP-PE) Data Confirms Statistically Superior Overall Survival in Osteosarcoma Patients
Date:11/1/2007

ting approval, whether regulatory authorities will approve L-MTP-PE within the time frame expected by the Company or at all, and whether the Company will be able to manufacture and commercialize L-MTP-PE even if it is approved by regulatory authorities. Other risks affecting the Company and its drug development programs include whether the Company or any of its collaborators will be able to develop pharmaceutical products using the technologies of the Company, whether clinical trial results to date are predictive of results of any future clinical trials, risks associated with completing clinical trials of product candidates, risks involved in the regulatory approval process for the Company's product candidates, the possibility that clinical testing may reveal undesirable and unintended side effects or other characteristics that may prevent or limit the commercial use of proposed products; whether the cash resources of the Company will be sufficient to fund operations as planned, including any further clinical trials of any of the Company's product candidates; whether any steps taken by the Company to contain costs will in fact result in sufficient reduction in expenses; reliance on key employees, especially senior management; the risk that the Company may not secure or maintain relationships with collaborators, and the Company's dependence on intellectual property. These factors are more fully discussed in the Company's Quarterly Report on Form 10-Q filed with the SEC for the quarter ended June 30, 2007 and other periodic reports filed with the SEC. The Company expressly disclaims any intent or obligation to update these forward-looking statements, except as required by law.


'/>"/>
SOURCE IDM Pharma, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Sygnis Pharma AG announces date for presentation of clinical results
2. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
9. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)...  Nektar Therapeutics (Nasdaq: NKTR ) will announce its ... on Wednesday, August 5, 2015, after the close of U.S.-based ... officer, will host a conference call to review the results ... (PT). The press release and a live ... a link that is posted on the home page and ...
(Date:7/29/2015)... CAMBRIDGE, Mass. , July 29, ... ), the leader in RNA-targeted therapeutics, and Akcea ... The New England Journal of Medicine ... study evaluating volanesorsen (formerly ISIS-APOCIII Rx ) in ... This publication follows the December 2014 publication in ...
(Date:7/29/2015)... PALO ALTO, Calif. , July 29, 2015 /PRNewswire/ ... announced it has, through one of its European subsidiaries, ... -based supplier of components and subsystems for X-ray ... will pay approximately €50 million in cash ... in August. Claymount is one of ...
Breaking Medicine Technology:Nektar to Announce Financial Results for the Second Quarter 2015 on Wednesday, August 5, 2015, After Close of U.S.-Based Financial Markets 2Nektar to Announce Financial Results for the Second Quarter 2015 on Wednesday, August 5, 2015, After Close of U.S.-Based Financial Markets 3Positive Clinical Data From Volanesorsen Published in the New England Journal of Medicine 2Positive Clinical Data From Volanesorsen Published in the New England Journal of Medicine 3Positive Clinical Data From Volanesorsen Published in the New England Journal of Medicine 4Positive Clinical Data From Volanesorsen Published in the New England Journal of Medicine 5Positive Clinical Data From Volanesorsen Published in the New England Journal of Medicine 6Positive Clinical Data From Volanesorsen Published in the New England Journal of Medicine 7Varian Medical Systems Acquiring Claymount to Expand Imaging Components Portfolio 2Varian Medical Systems Acquiring Claymount to Expand Imaging Components Portfolio 3Varian Medical Systems Acquiring Claymount to Expand Imaging Components Portfolio 4
... tradition as a leader in advanced technology for patient care, ... free public open house to unveil the latest innovation in ... What is a "Smart Room?" The Smart Room ... for improved quality and efficiency. This new technological approach sends ...
... Ventus Medical, Inc. a privately-held medical device ... sleep-disordered breathing, today announced that it has received ... (Photo:   http://photos.prnewswire.com/prnh/20110209/SF45785-b ) ... are pleased to accomplish this important regulatory milestone. ...
Cached Medicine Technology:DMC Harper-Hutzel Hospitals Unveil Most Advanced 'Smart Rooms!' 2Ventus Medical Receives CE Mark for Provent® Sleep Apnea Therapy 2
(Date:7/29/2015)... ... 2015 , ... Avatar Solutions has received official approval from CMS to administer ... CAHPS for PQRS Survey collects information about patients’ experiences of care within ... participate or they will receive a 2% penalty in 2017. At this point in ...
(Date:7/29/2015)... ... July 29, 2015 , ... This past week, CARE Surrogacy Center Mexico ... treasured member of the CARE extended family. , By shedding light on positive ... across the globe gain a newfound perspective on surrogacy in Mexico. The center wholeheartedly ...
(Date:7/29/2015)... ... July 29, 2015 , ... Andrzej Klos, M.D., has been reviewed and ... for nearly 38 years, is motivated each and every day by his sincere desire ... shine alongside his many awards and accolades, which include multiple listings in many highly ...
(Date:7/29/2015)... ... 2015 , ... Potomac Pilates, an elite Washington, D.C. metro area-based Pilates studio, ... ® by Potomac Pilates. On Thursday, July 30, Potomac Pilates will unveil its ... Potomac Pilates will continue to offer the same classes and personal experiences their clients ...
(Date:7/29/2015)... ... , ... Ticket Down is a reliable source of authentic tickets for the ... , The international soccer schedule of matches played on American soil continues to grow ... of the world’s greatest teams, Brazil, will travel to North America to compete with ...
Breaking Medicine News(10 mins):Health News:Avatar Solutions Approved to Administer CAHPS for Physician Quality Reporting System (PQRS) 2Health News:Avatar Solutions Approved to Administer CAHPS for Physician Quality Reporting System (PQRS) 3Health News:Heartfelt Interview Shows Extraordinary Impact of CARE Surrogacy Center Mexico 2Health News:Heartfelt Interview Shows Extraordinary Impact of CARE Surrogacy Center Mexico 3Health News:NJ Top Docs Presents, Dr. Andrzej Klos of Carepoint Health Pediatrics! 2Health News:NJ Top Docs Presents, Dr. Andrzej Klos of Carepoint Health Pediatrics! 3Health News:Same Great Pilates Studio, New Brand - Rock the Reformer 2Health News:Cheap USA vs. Brazil Tickets at Gillette Stadium: Ticket Down Cuts Presale Ticket Prices for Brazil vs. USA Men's National Soccer Team (USMNT) at Gillette Stadium 2Health News:Cheap USA vs. Brazil Tickets at Gillette Stadium: Ticket Down Cuts Presale Ticket Prices for Brazil vs. USA Men's National Soccer Team (USMNT) at Gillette Stadium 3
... seem like unlikely heroes in the battle against drug abuse, but ... dozens of human disease could claim that role. Scientists are ... more convenient animal model for studying the effects of cocaine and ... in ACS Chemical Neuroscience , a new monthly journal. ...
... high cholesterol and become obese? The same way as people ... fats. More importantly, according to two new studies led ... the same molecular mechanisms as humans to help maintain proper ... that contributes to obesity. The findings mean that as researchers ...
... ... Awards in October. , ... Raton, Fla. (PRWEB) December 2, 2009 -- ILS Technology, LLC, an industry leader in enabling ... recognized with awards for technical innovation to the industry., , , , ,On October 7th ...
... Holly Potter, vice president, Public Relations, National Media and Stakeholder ... at PR News, PR People luncheon held at ... PR People Awards competition showcases the top innovators and ... matter in the marketplace. The winners of this year,s program ...
... , SAN DIEGO, Dec. 2 US ... Nursery and Wellness products, is pleased to announce it will ... Oakland, Calif., at the Oakland Zoo on December 11-20, 2009. ... Department at 877-90-FARMS or visit http://cookswareafaire.com , Victor ...
... , ... Create Change campaign , WASHINGTON, Dec. 2 The ... year to help fund American Red Cross disaster response. ... $350,000, was given to help Philippine communities affected by typhoons ...
Cached Medicine News:Health News:Latest epidemic? High cholesterol, obesity in fruit flies 2Health News:Latest epidemic? High cholesterol, obesity in fruit flies 3Health News:ILS Technology and Customer ASML Recipients of Industry Recognition Awards 2Health News:Kaiser Permanente Public Relations Leader Wins PR People Award 2Health News:Kaiser Permanente Public Relations Leader Wins PR People Award 3Health News:US Farms, Inc. Showcasing Aloe365(TM) Product Line at Cook'sware A'faire at Oakland Zoo 2Health News:Hewlett-Packard Company Foundation Donates $1 Million for Red Cross Disaster Response 2Health News:Hewlett-Packard Company Foundation Donates $1 Million for Red Cross Disaster Response 3
This modular benchtop fume hood ventilates and purifies chemical fumes, allowing safe indoor release of exhaust. Bonded charcoal filters remove most organic contaminants. Options include final HEPA f...
... The spot fume hood mounts on ... 25cm x 12.7mm (10" x 1/2" ) ... open cone is placed above the source ... (1/2") I.D. tubing which connects to an ...
... exhaust hoods are designed to rest on ... a stream of air across the top ... Other sizes and types of hoods such ... available on special order in materials such ...
... Hood is an economical unit designed for ... number of fume hoods are needed. Excellent ... universities. Features include a one-piece shell molded ... corners for easy cleaning. A clear acrylic ...
Medicine Products: